BioPharm International Supplements, January 2010 - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

BioPharm International Supplements, January 2010
Articles
New Approaches to Improved Vaccine Manufacturing in Embryonated Eggs
By Eluemuno R. Blyden, PhD , Peter K. Watler, PhD
Recombinant vector technologies can improve the yield and lower the cost of egg-based influenza vaccine production.
Optimizing Vaccine Adjuvant Filtration
By Christina Carbrello , Marc Rogers
The viscosity of oily emulsions can reduce filter capacity and bacterial retention.
Advancing Adjuvants and Vaccine Delivery Systems for Better Vaccination Strategies
By Crystal Chan , Shirley Toms , Paul Hodgson , Andrew Potter
This article presents ongoing research at VIDO-InterVac for the development of safer and more effective adjuvants. These include adjuvants that stimulate innate immunity in the body and combination adjuvants.
Influenza Vaccine Enhancement with Immunomodulating Peptide Thymosin Alpha 1
By Cynthia W. Tuthill , Stefan Gravenstein , William B. Ershler
Clinical studies have shown that treatment with thymosin alpha 1 increases response to vaccination.
Advertisers in This Issue
Florida Biologix
Xcellerex
New Brunswick Scientific
Catalent Pharma Solutions

ADVERTISEMENT

ADVERTISEMENT

Click here